HC Wainwright & Co. Reiterates Neutral on CareDx
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Yi Chen has reiterated a neutral rating on CareDx (NASDAQ:CDNA).
August 09, 2023 | 2:43 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HC Wainwright & Co. has reiterated a neutral rating on CareDx, indicating no change in the company's stock outlook.
The neutral rating from HC Wainwright & Co. suggests that they believe CareDx's stock will perform in line with the market or sector average. This is unlikely to cause significant movement in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 60
RELEVANCE 100